对注意力缺陷/多动障碍的潜在治疗方法:专注于III期试验
Hurşit Ferahkaya1, Ayhan Bilgic2
1Department of Child and Adolescent Psychiatry, Necmettin Erbakan University, Konya, Turkey.
Expert opinion on pharmacotherapy
|September 23, 2025
概括
对注意力缺陷/多动障碍 (ADHD) 的新药正在晚期开发,针对新的机制,以提高超越当前治疗的疗效和耐受性. 这些有前途的药物可以为ADHD患者提供更好的症状控制和坚持.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 临床试验 临床试验
背景情况:
- 目前的注意力缺陷/多动症 (ADHD) 治疗方法,包括兴奋剂和非兴奋剂,对许多患者的有效性和耐受性都有局限性.
- 对于解决其他神经生物学途径的新型ADHD药物疗法,存在重大未满足的需求.
研究的目的:
- 审查在第三阶段开发或最近完成的试验中用于ADHD的新兴药理学药物.
- 评估有希望的新型ADHD药物的作用机制,疗效,安全性和监管状况.
- 评估这些新型治疗方法在ADHD管理中填补现有的治疗缺口的潜力.
主要方法:
- 在PubMed和ClinicalTrials.gov的文献搜索 (2018年1月-2025年7月).
- 专注于四个关键候选药物:百纳法丁,索里亚姆醇,CTx-1301和NRCT-101SR.
- 对药理学概况,临床试验数据和潜在临床影响的分析.
主要成果:
- 在ADHD的晚期发育中确定了四种有前途的药物 (Centanafadine,Solriamfetol,CTx-1301,NRCT-101SR).
- 这些药物探索新的点,包括更广泛的单氨基系统和先进的药物输送配方.
- 新出现的数据表明,改善症状控制和患者坚持治疗的潜力.
结论:
- 针对不同神经生物学机制的新药疗法正在推动ADHD治疗.
- 延长释放配方和新的药物点可能会提高疗效和耐受性.
- 这些新兴的治疗方法有可能显著改变ADHD药物治疗的格局.
关键词:
注意力缺陷/多动症障碍 注意力缺陷/多动症在 CTx-1301 中使用.在 NRCT-101SR 中.百纳法丁 (Centanafadine) 是一种百纳法丁 (Centanafadine) 的一种药物.第三阶段试验的试验.索里亚姆芬托尔 (Solriamfetol) 是一种可靠的药物.更多相关视频
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
6.3K
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
10.8K
相关概念视频
01:30Attention-Deficit/Hyperactivity Disorder
709
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:22Alzheimer's Disease: Treatment
736
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
736
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
01:24Parkinson's Disease: Treatment
931
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
931